BI Asset Management Fondsmaeglerselskab’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.13M | Buy |
|
|||||
|
2025
Q2 | $617K | Sell |
|
|||||
|
2025
Q1 | $546K | Sell |
|
|||||
|
2024
Q4 | $1.68M | Sell |
|
|||||
|
2024
Q3 | $1.99M | Buy |
|
|||||
|
2024
Q2 | $196K | Sell |
|
|||||
|
2024
Q1 | $681K | Buy |
|
|||||
|
2023
Q4 | $488K | Buy |
|
|||||
|
2023
Q3 | $159K | Hold |
|
|||||
|
2023
Q2 | $133K | Sell |
|
|||||
|
2023
Q1 | $1.1M | Buy |
|
|||||
|
2022
Q4 | $527K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $15K | Buy |
|